Drug Discovery World

APRIL 29, 2024

Dr Andrew Lewis, Chief Scientific Officer; Kieron Hall, Chief Marketing Officer; and Eric Bironneau, Chief Business Officer, Quotient Sciences: Lewis has held various scientific leadership positions at Quotient and was previously Director of Novel Drug Delivery Technologies at Ipsen.

Drugs 52

Drugs Sales Gene Therapy Life Science 52

Drug Discovery World

NOVEMBER 8, 2023

Sebastian Jaeger, PhD, Senior Scientist, ADCs & Targeted NBE Therapeutics, Merck Healthcare KGaA, on: ‘Evaluation of Fcab-drug conjugates as a novel antibody-based format for targeted drug delivery’. The presentations which follow include: Peter Tessier, PhD, Albert M.

Antibody 64

Antibody Engineer Protein Scientist 64

Drug Discovery World

NOVEMBER 9, 2023

The following presentations will follow: Mercedes Márquez Martínez, PhD, Technical Coordinator & Acting Scientific Director, Protein Production Platform (PPP) – Nanbiosis, Autonomous, University of Barcelona (UAB), on: ‘Host comparative production of recombinant proteins for assembling as nano- and micro-scale materials for drug delivery’.

Engineer 52

Engineer Antibody Protein In-Vivo 52